Paul D. Robbins

72.3k total citations · 15 hit papers
530 papers, 38.1k citations indexed

About

Paul D. Robbins is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Paul D. Robbins has authored 530 papers receiving a total of 38.1k indexed citations (citations by other indexed papers that have themselves been cited), including 252 papers in Molecular Biology, 208 papers in Genetics and 134 papers in Immunology. Recurrent topics in Paul D. Robbins's work include Virus-based gene therapy research (173 papers), RNA Interference and Gene Delivery (70 papers) and Immunotherapy and Immune Responses (69 papers). Paul D. Robbins is often cited by papers focused on Virus-based gene therapy research (173 papers), RNA Interference and Gene Delivery (70 papers) and Immunotherapy and Immune Responses (69 papers). Paul D. Robbins collaborates with scholars based in United States, Germany and South Korea. Paul D. Robbins's co-authors include Adrián E. Morelli, Laura J. Niedernhofer, Christopher H. Evans, Steven C. Ghivizzani, Hideaki Tahara, Michael T. Lotze, Andrea Gambotto, James L. Kirkland, Tamar Tchkonia and Simon C. Watkins and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Paul D. Robbins

524 papers receiving 37.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of immune responses by extracellular vesicles

2014 1.8k citations Paul D. Robbins et al. profile →
Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors

2015 803 citations Tamar Tchkonia, Laura J. Niedernhofer et al. profile →
A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

2001 792 citations Paul D. Robbins et al. profile →
Negative regulation of the Apaf-1 apoptosome by Hsp70

2000 681 citations Paul D. Robbins et al. profile →
Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

2009 532 citations Paul D. Robbins, Christopher H. Evans et al. profile →
New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463

2017 531 citations Laura J. Niedernhofer, Paul D. Robbins et al. profile →
Identification of HSP90 inhibitors as a novel class of senolytics

2017 506 citations Tamar Tchkonia, James L. Kirkland et al. profile →
Clonal Isolation of Muscle-Derived Cells Capable of Enhancing Muscle Regeneration and Bone Healing

2000 505 citations Joon Yung Lee, James H. Cummins et al. profile →
A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues

2022 453 citations Paul D. Robbins, Laura J. Niedernhofer et al. profile →
The Clinical Potential of Senolytic Drugs

2017 394 citations James L. Kirkland, Tamar Tchkonia et al. profile →
Cellular senescence: a key therapeutic target in aging and diseases

2022 358 citations Matthew J. Yousefzadeh, Laura J. Niedernhofer et al. Journal of Clinical Investigation profile →
Targeting cellular senescence with senotherapeutics: senolytics and senomorphics

2022 350 citations Laura J. Niedernhofer, Paul D. Robbins et al. profile →
Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice

2021 180 citations Tatiana D. Saccon, Ravinder Nagpal et al. The Journals of Gerontology Series A profile →
Immune Senescence, Immunosenescence and Aging

2022 148 citations Paul D. Robbins et al. profile →
Cellular Senescence in Intervertebral Disc Aging and Degeneration: Molecular Mechanisms and Potential Therapeutic Opportunities

2023 96 citations Prashanta Silwal, Yanshan Wang et al. Biomolecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul D. Robbins United States	105	18.6k	9.2k	7.1k	5.6k	5.6k	530	38.1k
Anita B. Roberts United States	120	31.6k 1.7×	6.2k 0.7×	5.7k 0.8×	10.4k 1.9×	4.9k 0.9×	288	53.4k
Erwin F. Wagner Austria	115	33.7k 1.8×	7.5k 0.8×	5.7k 0.8×	14.2k 2.5×	2.9k 0.5×	364	50.7k
Toshio Suda Japan	120	32.9k 1.8×	12.0k 1.3×	4.1k 0.6×	17.0k 3.0×	4.2k 0.8×	730	59.1k
Tatsuhiko Kodama Japan	89	20.1k 1.1×	9.3k 1.0×	2.5k 0.4×	6.7k 1.2×	4.8k 0.9×	426	36.3k
George Kollias Greece	89	12.1k 0.7×	10.9k 1.2×	3.1k 0.4×	5.6k 1.0×	1.7k 0.3×	306	30.3k
Diane Mathis United States	125	13.5k 0.7×	32.5k 3.5×	10.0k 1.4×	6.0k 1.1×	5.0k 0.9×	382	51.6k
Yoichiro Iwakura Japan	126	18.2k 1.0×	32.8k 3.6×	3.9k 0.6×	7.8k 1.4×	4.5k 0.8×	694	61.6k
Jack Gauldie Canada	95	8.2k 0.4×	9.1k 1.0×	3.0k 0.4×	4.4k 0.8×	3.5k 0.6×	416	31.9k
Steffen Gay Switzerland	103	13.8k 0.7×	8.1k 0.9×	2.6k 0.4×	5.0k 0.9×	3.6k 0.6×	523	36.4k
Stefan Rose‐John Germany	109	13.7k 0.7×	18.4k 2.0×	3.0k 0.4×	17.4k 3.1×	3.5k 0.6×	564	47.9k

Countries citing papers authored by Paul D. Robbins

Since Specialization

Citations

This map shows the geographic impact of Paul D. Robbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Robbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Robbins more than expected).

Fields of papers citing papers by Paul D. Robbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Robbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Robbins. The network helps show where Paul D. Robbins may publish in the future.

Co-authorship network of co-authors of Paul D. Robbins

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Robbins. A scholar is included among the top collaborators of Paul D. Robbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Robbins. Paul D. Robbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Jie, Yajun Zhang, Ying Li, et al.. (2025). NK‐Cell‐Derived Extracellular Vesicles Engineered to Carry Senolytics Eliminate Chemotherapy‐Induced Senescent Osteosarcoma Cells. Journal of Extracellular Vesicles. 14(7). e70123–e70123.

Silwal, Prashanta, et al.. (2023). Cellular Senescence in Intervertebral Disc Aging and Degeneration: Molecular Mechanisms and Potential Therapeutic Opportunities. Biomolecules. 13(4). 686–686. 96 indexed citations breakdown →

Saccon, Tatiana D., Ravinder Nagpal, Hariom Yadav, et al.. (2021). Senolytic Combination of Dasatinib and Quercetin Alleviates Intestinal Senescence and Inflammation and Modulates the Gut Microbiome in Aged Mice. The Journals of Gerontology Series A. 76(11). 1895–1905. 180 indexed citations breakdown →

Hartman, Robert A., Prakash Patil, Claudette M. St. Croix, et al.. (2018). Age-dependent changes in intervertebral disc cell mitochondria and bioenergetics. European Cells and Materials. 36. 171–183. 33 indexed citations

Evans, Christopher H., Steven C. Ghivizzani, & Paul D. Robbins. (2017). Gene Delivery to Joints by Intra-Articular Injection. Human Gene Therapy. 29(1). 2–14. 96 indexed citations

Tilstra, Jeremy S., Andria R. Robinson, Jin Wang, et al.. (2012). NF-κB inhibition delays DNA damage–induced senescence and aging in mice. Journal of Clinical Investigation. 122(7). 2601–2612. 367 indexed citations

Evans, Christopher H., Paul D. Robbins, Steven C. Ghivizzani, et al.. (2005). Gene transfer to human joints: Progress toward a gene therapy of arthritis. Proceedings of the National Academy of Sciences. 102(24). 8698–8703. 153 indexed citations

Lattermann, Christian, Axel W.A. Baltzer, Boris A. Zelle, et al.. (2004). Feasibility of Percutaneous Gene Transfer to an Atrophic Nonunion in a Rabbit. Clinical Orthopaedics and Related Research. 425(425). 237–243. 8 indexed citations

Robbins, Paul D., et al.. (2003). The role of the transcription factor DP in apoptosis. APOPTOSIS. 8(5). 461–468. 50 indexed citations

10.

Lee, Joon Yung, Douglas S. Musgrave, Dalip Pelinkovic, et al.. (2001). Effect of Bone Morphogenetic Protein-2-Expressing Muscle-Derived Cells on Healing of Critical-Sized Bone Defects in Mice. Journal of Bone and Joint Surgery. 83(7). 1032–1039. 175 indexed citations

11.

Mi, Zhibao, Steven C. Ghivizzani, Eric R. Lechman, et al.. (2000). Adenovirus-mediated gene transfer of insulin-like growth factor 1 stimulates proteoglycan synthesis in rabbit joints. Arthritis & Rheumatism. 43(11). 2563–2570. 76 indexed citations

12.

Kim, Seon Hee, Sunyoung Kim, & Paul D. Robbins. (2000). Retroviral vectors. Advances in virus research. 55. 545–563. 15 indexed citations

13.

Evans, Christopher H., Steven C. Ghivizzani, Peter J. Smith, et al.. (2000). Using Gene Therapy to Protect and Restore Cartilage. Clinical Orthopaedics and Related Research. 379(379 Suppl). S214–S219. 71 indexed citations

14.

Lu, Liwei, Andrea Gambotto, Sixuan Qian, et al.. (1999). Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Therapy. 6(4). 554–563. 83 indexed citations

15.

Evans, Christopher H., et al.. (1999). Review Lessons learned from gene transfer approaches. 1 indexed citations

16.

Wehling, Peter, Klaus-Peter Schulitz, Paul D. Robbins, Christopher H. Evans, & J. Reinecke. (1997). Transfer of Genes to Chondrocytic Cells of the Lumbar Spine. Spine. 22(10). 1092–1097. 75 indexed citations

17.

DeKosky, Steven T., Scot Styren, Mark E. O’Malley, et al.. (1996). Interleukm‐1 receptor antagonist suppresses neurotrophin response in injured rat brain. Annals of Neurology. 39(1). 123–127. 84 indexed citations

18.

Pitt, Bruce R. & Paul D. Robbins. (1996). Fetal gene therapy. Molecular Human Reproduction. 2(7). 467–469. 1 indexed citations

19.

Barranger, J. A., M Nimgaonkar, Edward D. Ball, et al.. (1995). Gene therapy for genetic disease. 10(1). 5–9. 4 indexed citations

20.

Robbins, Paul D., et al.. (1995). Section Review: Biologicals & Immunologicals: Gene therapy as a treatment for rheumatoid arthritis. Expert Opinion on Investigational Drugs. 4(9). 843–852. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact